aprott/iStock via Getty Images Novo Nordisk (NVO) announced Friday that its popular obesity therapy, semaglutide,
Bet_Noire Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as
Short interest for healthcare stocks in S&P 500 rose slightly in December vs. November, while
Nikolay Pandev London (UKX) +0.67% Annual inflation rate in the UK unexpectedly edged lower to
Rimma_Bondarenko/iStock via Getty Images Eli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based
jetcityimage/iStock Editorial via Getty Images Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the
Nikolay Pandev London (UKX) -0.06% Germany (DAX:IND) +0.64% France (CAC:IND) +0.98% The pan-European Stoxx 600
2d illustrations and photos Metsera (MTSR), which is developing ultra-long-acting drugs for the treatment of
jetcityimage Eli Lilly (NYSE:LLY) has reportedly asked the Biden administration to pause negotiations over drug
Eli Lilly (NYSE:LLY) CEO Dave Ricks said Monday that the company’s GLP-1 weight-loss pill orforglipron